A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer

Current pemetrexed/platinum chemotherapy does not produce a satisfactory therapeutic response in advanced lung cancer patients. The aim of this study was to determine whether the administration of gefitinib, a tyrosine kinase inhibitor (TKI), intercalated with pemetrexed/platinum could improve the e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu, Hui, Zhang, Jian, Wu, Xianghua, Luo, Zhiguo, Wang, Huijie, Sun, Si, Peng, Wei, Qiao, Jie, Feng, Yu, Wang, Jialei, Chang, Jianhua
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2014
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100984/
https://ncbi.nlm.nih.gov/pubmed/24755888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.28874
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares